The antimicrobial peptide LL‐37 modulates the inflammatory and host defense response of human neutrophils

The human cathelicidin antimicrobial peptide acts as an effector molecule of the innate immune system with direct antimicrobial and immunomodulatory effects. The aim of this study was to test whether the cathelicidin LL‐37 modulates the response of neutrophils to microbial stimulation. Human neutrophils were exposed to LPS, Staphylococcus aureus and Pseudomonas aeruginosa subsequent to incubation with LL‐37 and cytokine release was measured by ELISA. The incubation with LL‐37 significantly decreased the release of proinflammatory cytokines from stimulated human neutrophils. ROS production of neutrophils was determined by a luminometric and a flow cytometry method. The peptide induced the production of ROS and the engulfment of bacteria into neutrophils. Peritoneal mouse neutrophils isolated from CRAMP‐deficient and WT animals were treated with LPS and TNF‐α in the supernatant was measured by ELISA. Antimicrobial activity of neutrophils was detected by incubating neutrophils isolated from CRAMP‐knockout and WT mice with bacteria. Neutrophils from CRAMP‐deficient mice released significantly more TNF‐α after bacterial stimulation and showed decreased antimicrobial activity as compared to cells from WT animals. In conclusion, LL‐37 modulates the response of neutrophils to bacterial activation. Cathelicidin controls the release of inflammatory mediators while increasing antimicrobial activity of neutrophils.

[1]  J. Shively,et al.  Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophils , 2009, European journal of immunology.

[2]  L. Foster,et al.  Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes1 , 2009, The Journal of Immunology.

[3]  A. Zychlinsky,et al.  Fungal and bacterial killing by neutrophils. , 2009, Methods in molecular biology.

[4]  J. Shively,et al.  Neutrophil secondary necrosis is induced by LL‐37 derived from cathelicidin , 2008, Journal of leukocyte biology.

[5]  I. Nagaoka,et al.  Cathelicidin LL‐37 induces the generation of reactive oxygen species and release of human α‐defensins from neutrophils , 2007, The British journal of dermatology.

[6]  R. Bals,et al.  Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats , 2007, Anesthesiology.

[7]  A. Hovnanian,et al.  Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea , 2007, Nature Medicine.

[8]  A. Di Nardo,et al.  Cathelicidin Antimicrobial Peptides Block Dendritic Cell TLR4 Activation and Allergic Contact Sensitization1 , 2007, The Journal of Immunology.

[9]  H. Malech.  The role of neutrophils in the immune system: an overview. , 2007, Methods in molecular biology.

[10]  C. Vogelmeier,et al.  The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. , 2006, International immunology.

[11]  T. S. Wilkinson,et al.  The human cationic host defense peptide LL‐37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system , 2006, Journal of leukocyte biology.

[12]  T. Hökfelt,et al.  The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection , 2006, Nature Medicine.

[13]  I. Nagaoka,et al.  An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X71 , 2006, The Journal of Immunology.

[14]  Fiona S. L. Brinkman,et al.  Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-371 , 2006, The Journal of Immunology.

[15]  Y. Shai,et al.  Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides , 2006, Journal of Biological Chemistry.

[16]  W. Shafer,et al.  Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages , 2005, Cellular microbiology.

[17]  M. Zanetti.  The role of cathelicidins in the innate host defenses of mammals. , 2005, Current issues in molecular biology.

[18]  B. Conway,et al.  Burkholderia cenocepacia Induces Neutrophil Necrosis in Chronic Granulomatous Disease1 , 2005, The Journal of Immunology.

[19]  M. Wewers,et al.  A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1β Processing and Release1 , 2004, The Journal of Immunology.

[20]  D. Hoover,et al.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. , 2004, Annual review of immunology.

[21]  R. Hancock,et al.  The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization , 2004, The Journal of Immunology.

[22]  Robert E. W. Hancock,et al.  The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization1 , 2004, The Journal of Immunology.

[23]  I. Nagaoka,et al.  Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats , 2004, Pediatric Surgery International.

[24]  K. Rabe,et al.  The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor 1 , 2003, The Journal of Immunology.

[25]  A. Bennaceur-Griscelli,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2002 .

[26]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[27]  M. Ståhle-Bäckdahl,et al.  The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. , 2003, The Journal of investigative dermatology.

[28]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[29]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[30]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[31]  I. Nagaoka,et al.  Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-α by Blocking the Binding of LPS to CD14+ Cells1 , 2001, The Journal of Immunology.

[32]  I. Nagaoka,et al.  Evaluation of the effects of peptide antibiotics human β‐defensins‐1/‐2 and LL‐37 on histamine release and prostaglandin D2 production from mast cells , 2001 .

[33]  I. Nagaoka,et al.  Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. , 2001, European journal of immunology.

[34]  H. Jörnvall,et al.  The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.

[35]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[36]  A. Karlsson,et al.  Respiratory burst in human neutrophils. , 1999, Journal of immunological methods.

[37]  James M. Wilson,et al.  Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide , 1999, Infection and Immunity.

[38]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Kirikae,et al.  Protective Effects of a Human 18-Kilodalton Cationic Antimicrobial Protein (CAP18)-Derived Peptide against Murine Endotoxemia , 1998, Infection and Immunity.

[40]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[41]  J. Odeberg,et al.  The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.

[42]  J. Odeberg,et al.  FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.